已收盘 12-19 16:00:00 美东时间
+0.180
+1.00%
CTNM: -20% | Contineum Therapeutics shares are trading lower after the company announced that topline data from its Phase 2 VISTA trial of PIPE-307 did not meet its primary or secondary efficacy
11-21 20:16
2025 Full Year OutlookCurrentPriorGAAP Loss From Continuing Operations$(103) - $(93) million$(74) - $(56) millionAdjusted EBITDA$268 - $278 million$290 - $310 millionGAAP Diluted Earnings/(Loss) Per Share from Continuing
11-10 20:08
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
11-10 19:12
04:50 PM EDT, 08/29/2024 (MT Newswires) -- Enviri (NVRI) sold its Reed Minerals unit to Speyside Equity for $45 million in cash with potential adjustments following the closing. Net cash proceeds will be used to pay down debt and improve the balance sheet, Enviri said Thursday in a statement. The co...
2024-08-30 04:50
Enviri Corporation (NYSE:NVRI) announced today that it has sold its Reed Minerals business to Speyside Equity for $45 million in cash, subject to post-closing adjustments. Enviri expects to use the net cash proceeds from the transaction to reduce debt and further strengthen its balance sheet. Import...
2024-08-30 04:30